Diet and insulinlike growth factor I in relation to body composition in women with exercise-induced hypothalamic amenorrhea.
To assess the potential influence of diet and endogenous peptide anabolic hormone secretion on exercise-related differences in body composition, we compared levels of macronutrient intake, insulinlike growth factor I (IGF-I), and fat-free mass (FFM) and fat mass (FM) in matched groups of exercising women with and without secondary hypothalamic amenorrhea. Women were tightly matched according to somatotype and grouped into those with exercise amenorrhea (EXam, n = 6), exercise eumennorhea (EXeu, n = 5), and sedentary eumennorheic controls (SED, n = 5). Although no between-group difference was observed in FFM, the EXeu subjects had a significantly lower fat fraction and a significantly elevated FFM/FM ratio. Kilocaloric and protein intakes did not differ between groups, but dietary fat intake was lowest and carbohydrate intake highest in the EXam subjects. Dietary macronutrients were not correlated with the FFM/FM ratio. However, levels of insulinlike growth factor I were significantly correlated to the FFM/FM ratio and there was a clear trend for the hormone to be highest in the EXeu subjects. We conclude that differences in body composition between exercising women with and without exercise-induced hypothalamic-pituitary dysfunction were related to an alteration in IGF-I secretion, although differences in macronutrient intake might also be a factor. Further studies are warranted to elaborate upon the dietary and hormonal factors regulating the body composition response to exercise.
Crist
D M
DM
Department of Medicine, University of New Mexico School of Medicine, Albuquerque 87131.
Hill
J M
JM
D000273:Adipose Tissue / Q000033:anatomy & histology; D000328:Adult; D000367:Age Factors; D000568:Amenorrhea / Q000503:physiopathology; D001823:Body Composition; D001827:Body Height; D015992:Body Mass Index; D001835:Body Weight; D004032:Diet; D015444:Exercise / Q000502:physiology*; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D010807:Physical Endurance; D013002:Somatomedins / Q000378:metabolism*; D013008:Somatotypes
D013002:Somatomedins; D007334:Insulin-Like Growth Factor I